Anthony GagliardiJefferson Twp, NJ

Anthony Gagliardi Phones & Addresses

Oak Ridge, NJ

1 Petersburg Ct, Oak Ridge, NJ 07438 (201) 939-0840

Work

Position: Executive, Administrative, and Managerial Occupations

Education

Degree: Associate degree or higher

Ranks

Licence: Dist. of Columbia - Active Date: 1984

Mentions for Anthony Gagliardi

Career records & work history

Lawyers & Attorneys

Anthony Gagliardi Photo 1

Anthony C Gagliardi - Lawyer

Address:
(301) 884-8780 (Office)
Licenses:
Dist. of Columbia - Active 1984

Anthony Gagliardi resumes & CV records

Resumes

Anthony Gagliardi Photo 40

Anthony Gagliardi

Anthony Gagliardi Photo 41

Anthony Gagliardi

Anthony Gagliardi Photo 42

Anthony Gagliardi

Anthony Gagliardi Photo 43

Anthony Gagliardi

Work:
Anthony S Studio 7
Owner
Anthony Gagliardi Photo 44

Anthony Gagliardi

Location:
United States
Anthony Gagliardi Photo 45

Anthony Gagliardi

Location:
United States

Publications & IP owners

Us Patents

Methods And Compositions For The Targeted Modification Of A Genome

US Patent:
2016006, Mar 3, 2016
Filed:
Oct 30, 2015
Appl. No.:
14/928180
Inventors:
- Tarrytown NY, US
Wojtek Auerbach - Ridgewood NJ, US
Ka-Man Venus Lai - Tarrytown NY, US
Alexander O. Mujica - Elmsford NY, US
Jeffrey D. Lee - New York NY, US
Gustavo Droguett - New City NY, US
Sean Trzaska - Bayside NY, US
Charleen Hunt - Dumont NJ, US
Anthony Gagliardi - Hopewell Junction NY, US
Junko Kuno - Holmes NY, US
David M. Valenzuela - Yorktown Heights NY, US
George D. Yancopoulos - Yorktown Heights NY, US
Assignee:
REGENERON PHARMACEUTICALS, INC. - Tarrytown NY
International Classification:
C12N 15/90
C12N 15/85
C12N 15/10
Abstract:
Compositions and methods are provided for modifying a genomic locus of interest in a eukaryotic cell, a mammalian cell, a human cell or a non-human mammalian cell using a large targeting vector (LTVEC) comprising various endogenous or exogenous nucleic acid sequences as described herein. Further methods combine the use of the LTVEC with a CRISPR/Cas system. Compositions and methods for generating a genetically modified non-human animal comprising one or more targeted genetic modifications in their germline are also provided.

Methods And Compositions For The Targeted Modification Of A Genome

US Patent:
2015015, Jun 11, 2015
Filed:
Oct 15, 2014
Appl. No.:
14/515503
Inventors:
- TARRYTOWN NY, US
Wojtek Auerbach - Ridgewood NJ, US
Ka-Man Venus Lai - Tarrytown NY, US
Alexander O. Mujica - Elmsford NY, US
Jeffrey D. Lee - New York NY, US
Gustavo Droguett - New City NY, US
Sean Trzaska - Bayside NY, US
Charleen Hunt - Dumont NJ, US
Anthony Gagliardi - Hopewell Junction NY, US
Junko Kuno - Holmes NY, US
David M. Valenzuela - Yorktown Heights NY, US
George D. Yancopoulos - Yorktown Heights NY, US
International Classification:
C12N 15/90
C12N 15/85
Abstract:
Compositions and methods are provided for modifying a genomic locus of interest in a eukaryotic cell, a mammalian cell, a human cell or a non-human mammalian cell using a large targeting vector (LTVEC) comprising various endogenous or exogenous nucleic acid sequences as described herein. Further methods combine the use of the LTVEC with a CRISPR/Cas system. Compositions and methods for generating a genetically modified non-human animal comprising one or more targeted genetic modifications in their germline are also provided.

Methods And Compositions For The Targeted Modification Of A Genome

US Patent:
2015015, Jun 11, 2015
Filed:
Dec 19, 2014
Appl. No.:
14/578291
Inventors:
- Tarrytown NY, US
Wojtek Auerbach - Ridgewood NJ, US
Ka-Man Venus Lai - Tarrytown NY, US
Alexander O. Mujica - Elmsford NY, US
Jeffrey D. Lee - New York NY, US
Gustavo Droguett - New City NY, US
Sean Trzaska - Bayside NY, US
Charleen Hunt - Dumont NJ, US
Anthony Gagliardi - Hopewell Junction NY, US
Junko Kuno - Holmes NY, US
David M. Valenzuela - Yorktown Heights NY, US
George D. Yancopoulos - Yorktown Heights NY, US
International Classification:
C12N 15/90
Abstract:
Compositions and methods are provided for modifying a genomic locus of interest in a eukaryotic cell, a mammalian cell, a human cell or a non-human mammalian cell using a large targeting vector (LTVEC) comprising various endogenous or exogenous nucleic acid sequences as described herein. Further methods combine the use of the LTVEC with a CRISPR/Cas system. Compositions and methods for generating a genetically modified non-human animal comprising one or more targeted genetic modifications in their germline are also provided.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.